Literature DB >> 30865925

Parental obesity programs pancreatic cancer development in offspring.

Raquel Santana da Cruz, Johan Clarke, Ana Cristina P Curi, Aseel Al-Yawar, Lu Jin, Ali Baird, M Idalia Cruz, Bhaskar Kallakury, Sonia de Assis.   

Abstract

Epidemiological studies suggest that timing of obesity onset - and underlying metabolic dysfunction - is important in determining pancreatic cancer rates: early and young adult abdominal overweight/obesity is more strongly associated with this cancer than obesity that develops later in life. Parental obesity and overweight are associated with metabolic dysfunction and obesity in their children. Here, we evaluated the impact of parental overweight on offspring's susceptibility of pancreatic cancer using the P48Cre/+/KrasG12D/+ mouse model. Male mice were fed an obesity-inducing diet (OID) before conception and mated with females raised on a control diet (CO) to generate the offspring. In a separate experiment, pregnant dams were fed CO or OID throughout gestation. The resulting OID offspring from the maternal (OID-m) or paternal lineage (OID-p) were used to study body weight, metabolic parameters and pancreatic cancer development and for molecular analysis. Parental obesity increased offspring's body weight at birth, weaning and in adulthood compared to CO, with gender- and genotype-specific differences. OID-p and OID-m offspring showed metabolic disorder and accelerated development of high-grade PanIN/PDAC. OID offspring also had higher rates of acinar-to-ductal reprogramming assessed by CPA1+/SOX9+-positive pancreatic cells. Levels of Tenascin C (TNC), an ECM glycoprotein shown to suppress apoptosis, were elevated in OID offspring, particularly females. In line with that, OID offspring displayed increased collagen content and decreased apoptosis in pancreatic lesions compared to CO. An ancestral history of obesity through either the paternal or maternal lineages increases offspring's susceptibility to pancreatic cancer development.

Entities:  

Keywords:  developmental programming; obesity; pancreatic cancer

Mesh:

Substances:

Year:  2019        PMID: 30865925      PMCID: PMC6717698          DOI: 10.1530/ERC-19-0016

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  41 in total

Review 1.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.

Authors:  Shizhang Ling; Xiaofei Chang; Luciana Schultz; Thomas K Lee; Alcides Chaux; Luigi Marchionni; George J Netto; David Sidransky; David M Berman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

Review 3.  Obesity and cancer: the role of dysfunctional adipose tissue.

Authors:  Rob C M van Kruijsdijk; Elsken van der Wall; Frank L J Visseren
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-15       Impact factor: 4.254

4.  Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.

Authors:  Li Jiao; Amy Berrington de Gonzalez; Patricia Hartge; Ruth M Pfeiffer; Yikyung Park; D Michal Freedman; Mitchell H Gail; Michael C R Alavanja; Demetrius Albanes; Laura E Beane Freeman; Wong-Ho Chow; Wen-Yi Huang; Richard B Hayes; Jane A Hoppin; Bu-Tian Ji; Michael F Leitzmann; Martha S Linet; Cari L Meinhold; Catherine Schairer; Arthur Schatzkin; Jarmo Virtamo; Stephanie J Weinstein; Wei Zheng; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2010-04-10       Impact factor: 2.506

5.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

6.  Stronger influence of maternal than paternal obesity on infant and early childhood body mass index: the Fels Longitudinal Study.

Authors:  A M Linabery; R W Nahhas; W Johnson; A C Choh; B Towne; A O Odegaard; S A Czerwinski; E W Demerath
Journal:  Pediatr Obes       Date:  2012-10-08       Impact factor: 4.000

Review 7.  Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life.

Authors:  G Dörner; A Plagemann
Journal:  Horm Metab Res       Date:  1994-05       Impact factor: 2.936

8.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

9.  Paternal overweight is associated with increased breast cancer risk in daughters in a mouse model.

Authors:  Camile Castilho Fontelles; Elissa Carney; Johan Clarke; Nguyen M Nguyen; Chao Yin; Lu Jin; M Idalia Cruz; Thomas Prates Ong; Leena Hilakivi-Clarke; Sonia de Assis
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

10.  Paternal malnutrition programs breast cancer risk and tumor metabolism in offspring.

Authors:  Raquel Santana da Cruz; Elissa J Carney; Johan Clarke; Hong Cao; M Idalia Cruz; Carlos Benitez; Lu Jin; Yi Fu; Zuolin Cheng; Yue Wang; Sonia de Assis
Journal:  Breast Cancer Res       Date:  2018-08-30       Impact factor: 6.466

View more
  2 in total

Review 1.  Epigenetic Inheritance: Intergenerational Effects of Pesticides and Other Endocrine Disruptors on Cancer Development.

Authors:  Heloiza Diniz Nicolella; Sonia de Assis
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

2.  Systemic alterations play a dominant role in epigenetic predisposition to breast cancer in offspring of obese fathers and is transmitted to a second generation.

Authors:  Camile C Fontelles; Raquel Santana da Cruz; Alexandra K Gonsiewski; Ersilia Barin; Volkan Tekmen; Lu Jin; M Idalia Cruz; Olivier Loudig; Anni Warri; Sonia de Assis
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.